Evotec SE (EVO) Assets Average (2009 - 2026)
Evotec SE (EVO) reported Assets Average of $960898.9 for Q1 2026, down 99.91% on a YoY basis from $1.0 billion in Q1 2025, and down 7.36% sequentially from $1.0 million in Q4 2025.
Evotec SE (EVO) Assets Average (2009 - 2026) Analysis & Trends
Evotec SE (EVO) has 8 years of Assets Average data on file, last reported at $960898.9 in Q1 2026.
- For the quarter ending Q1 2026, Assets Average fell 99.91% year-over-year to $960898.9; the trailing twelve-month figure through Mar 2026 stood at $960898.9 (down 99.91% YoY), and the FY2025 full-year result was $1.0 billion, down 2.08% from the prior year.
- Assets Average fell to $960898.9 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $1226.2 billion in Q1 2022 to a low of $960898.9 in Q1 2026.
- A 4-year average of $391.2 billion and a median of $28.6 million in 2022 frame the typical range for Assets Average.
- Across the five-year window, Assets Average sank 100.0% in 2025 and slumped 99.91% in 2026, its largest moves.
- Tracing EVO's Assets Average over 4 years: stood at $28.6 million in 2022, then surged by 3822599.57% to $1094.2 billion in 2024, then slumped by 100.0% to $1.0 million in 2025, then decreased by 7.36% to $960898.9 in 2026.
- Business Quant data shows EVO's Assets Average at $960898.9 in Q1 2026, $1.0 million in Q4 2025, and $2.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Evotec SE | 351.60 Mn | 351.08 Mn | - | 960,898.94 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 960,898.94 |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 2.06 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 1.02 Bn |
| Dec 31, 2024 | 1,094.19 Bn |
| Mar 31, 2024 | 1,199.72 Bn |
| Dec 31, 2022 | 28.62 Mn |
| Mar 31, 2022 | 1,226.18 Bn |
| Dec 31, 2021 | 1,042.42 Bn |
| Dec 31, 2019 | 6.46 Mn |
| Sep 30, 2010 | 211,550.60 |
| Jun 30, 2010 | 100.16 Mn |
| Mar 31, 2010 | 100.18 Mn |
| Jun 30, 2009 | 224.44 Mn |
| Mar 31, 2009 | 235.96 Mn |